Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
French Senate debates social media ban for under-15s - 2Dominating Monetary Administration: A Bit by bit Manual for Making an Individual Financial plan
- 32024 Manual for Light Extravagance Room Feel: What's Moving
- 4'Euphoria' releases Season 3 photos with Zendaya, Sydney Sweeney, Jacob Elordi and others: See them
- 5The Advancement and Effect of Dental Embed Innovation on Oral Wellbeing
- Massachusetts court hears arguments in lawsuit alleging Meta designed apps to be addictive to kids
- Lily Allen 2026 'West End Girl' arena tour: How to get tickets, prices and more
- 6 Well known Ladies' Fragrances On the planet
- Why don’t humans have hair all over their bodies? A biologist explains our lack of fur
- Procter & Gamble changes Crest toothpaste packaging to address Texas AG fluoride concerns
- Which restaurants and fast food chains will be open on Christmas Eve and Christmas Day?
- New materials, old physics – the science behind how your winter jacket keeps you warm
- Hostages as leverage: Iran's secret demand aimed at crippling Israel's agriculture
- UN torture cm'tee report flags Israel for allegedly mistreating journalists, detainees, ex-MAG
